GlassScriptPhysician profile
Raymon Hanna
NPI 1518371616
$50,746.59
in general payments reported to CMS, 2019-2025
24 companies · $689 in 2025
The $689 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,939 · 2020: $193 · 2021: $598 · 2022: $1,261 · 2023: $35K · 2024: $9,169 · 2025: $689.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $44K · Food and Beverage: $751 · Long Term Medical Supply Or Device Loan: $307 · Education: $21.42.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $43,676.25 |
| Food and Beverage | $751.40 |
| Long Term Medical Supply Or Device Loan | $307.20 |
| Education | $21.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $44,286.47 | 2019-2025 | Grafix Pl, Collagenase Santyl, Pico 14 |
| Arthrex, INC. | $2,878.71 | 2019 | |
| Orthofix Medical, INC. | $1,033.33 | 2022-2024 | Physio-Stim |
| Paragon 28, INC. | $1,032.14 | 2019-2024 | Precision Mis Bunion |
| Integra Lifesciences Corporation | $401.92 | 2021-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Stryker Corporation | $390.48 | 2019-2025 | Valor, Hoffmann, Salvation |
| Organogenesis INC. | $107.27 | 2022-2025 | Via Matrix, Puraply |
| Kci USA, INC. | $76.97 | 2020-2023 | Prevena, V.A.C. Veraflo Cleanse Choice |
| Paratek Pharmaceuticals, INC. | $63.17 | 2022-2024 | Nuzyra |
| Solventum Corporation | $54.28 | 2024-2025 | V.A.C. Veraflo Cleanse Choice, Prevena, V.A.C.Ulta |
| Acera Surgical, INC. | $53.46 | 2022-2025 | Restrata Wound Matrix |
| Kerecis Limited | $52.03 | 2021-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Convatec INC. | $48.53 | 2023-2025 | |
| Acumed LLC | $38.24 | 2025 | Acumed, Osteomed |
| Horizon Therapeutics Plc | $37.08 | 2023 | Krystexxa |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Avita Medical Americas, LLC | $35.61 | 2025 | Recell, Cohealyx, Permeaderm |
| Depuy Synthes Sales INC. | $27.39 | 2025 | Motoband Cp |
| Amgen INC. | $26.65 | 2025 | Krystexxa |
| Fidia Pharma USA INC. | $20.49 | 2020 | |
| Coastal Medical Technologies LLC | $19.24 | 2025 | |
| Nevro Corp. | $18.91 | 2023 | Senza |
| Bsn Medical INC | $15.76 | 2025 | |
| Triad Life Sciences INC. | $14.49 | 2022 | |
| Hydrofera LLC | $13.97 | 2024 | Hydrofera Blue |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Raymon Hanna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.